Skip to main content
. Author manuscript; available in PMC: 2015 Oct 15.
Published in final edited form as: Cancer Res. 2014 Aug 21;74(20):5855–5865. doi: 10.1158/0008-5472.CAN-14-0799

Figure 1.

Figure 1

(a). Chemical structures of SAR405838 and MI-219. (b). Affinities of SAR405838 and control compounds to human MDM2 protein, determined in a fluorescence-polarization binding assay. (c). Co-crystal structure of SAR405838/MDM2 at 2.1 Å resolution. (d). Superposition of SAR405838/MDM2 and p53 peptide/MDM2 co-crystal structures.